title: Combination therapies in oculofacial rejuvenation.
abstract: The oculo-facial surgeon's quest for non-invasive procedures is a response to increasing patient demands for enhanced results without any downtime. Technology has obliged us with multiple injectable and light therapeutic modalities that tighten skin, relax and fill in wrinkles, and improve skin dyspigmentation and texture. When these techniques are combined, the results are superior to the use of individual therapies alone. The foundation for combination therapies are: botulinum toxin, filling agents, chemical peels, intense pulsed light, non-ablative and ablative lasers.
authors.affiliation: Manhattan Eye Ear and Throat Hospital, New York, NY, USA. bosniakzilkha@mindspring.com
authors.forename: Stephen
authors.initials: S
authors.lastname: Bosniak
authors.forename: Marian
authors.initials: M
authors.lastname: Cantisano-Zilkha
authors.forename: Baljeet K
authors.initials: BK
authors.lastname: Purewal
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Zdinak
mesh_terms: D019882:Blepharoplasty / Q000379:methods; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002615:Chemexfoliation; D003131:Combined Modality Therapy; D003357:Cosmetic Techniques; D006801:Humans; D006820:Hyaluronic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D028022:Low-Level Light Therapy; D009465:Neuromuscular Agents / Q000627:therapeutic use; D018579:Patient Selection; D012060:Rejuvenation; D015361:Rhytidoplasty / Q000379:methods*; D015595:Skin Aging
chemical_list: D009465:Neuromuscular Agents; D006820:Hyaluronic Acid; D019274:Botulinum Toxins, Type A; C445361:Restylane